San Francisco, California, April 11, 2018: A new research study by TMR Research offers an exhaustive assessment of the global market for influenza diagnostics. The research report, titled “Influenza Diagnostics Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” evaluates the growth drivers, hindrances, prominent trends, market potentials, opportunities, and the challenges to find out the future performance and the prospects of this market.
According to the research study, the rising prevalence of various forms of influenza across the world, together with the increasing investments in research and development, is boosting the global market for influenza diagnostics, remarkably. Apart from this the increasing focus on pediatric treatment, and the implementation of favorable policies of the government are also driving the overall market. Since faster and more correct diagnostic tests are sought after increasingly, a number of market participants have begun with the development of more effective tests that provide quicker results, which is likely to reflect greatly on this market over the next few years.
On the other hand, the presence of stringent regulatory frameworks, limited infrastructure, especially in developing countries, and delays in the approval process of new tests may surface as key restraints in the growth trajectory of the global market for influenza diagnostics. However, technological advancements in this domain is projected to offer lucrative opportunities for further growth in the near future, reports the market study.
Get Sample Copy of this Report @
In terms of the geography, the global market for influenza diagnostics can be divided into the Middle East and Africa, Latin America, North America, Asia Pacific, and Europe. With the increasing outbreaks of influenza among several countries, such as Australia, Greece, the U.S., China, India, Spain, and Malaysia have, the demand for influenza diagnostic techniques have been rising substantially across the world. Asia Pacific, among all, has been leading the global market and is anticipated to remain registering a significant surge over the period of the forecast. This rise can be attributed to the increase in the healthcare spending, greater demand for modern diagnostics technologies, favorable government initiatives, and surging disposable incomes of the middle class people in this region, reports the market study.
The competitive landscape of the global market for influenza diagnostics has also been examined in this research report. Becton, Dickinson and Co., Luminex Corp., Thermo Fisher Scientific, GlaxoSmithKline plc, Alere Inc., DiaSorin, SA Scientific, Roche Diagnostics, and Quidel Corp. are some of the key players in this market. Researchers have thoroughly studies the performance of these leading market players in order to understand the hierarchy between them, states the research report.